As the nurse responsible for Toby, a patient who is due for his regular dose of olanzapine (Zyprexa) and has scored a 4 on the AIMS (Abnormal Involuntary Movement Scale), there are several steps you would typically take:
1. Assess Toby's condition: First, you would assess Toby's overall physical and mental state. Evaluate if he is experiencing any abnormal movements or side effects related to the medication. This assessment helps you determine the appropriate course of action.
2. Consult with the prescribing doctor: Contact the doctor who prescribed olanzapine for Toby and inform them about his AIMS score of 4. This allows the doctor to review the situation and decide if any adjustments to Toby's medication regimen are necessary. The doctor may want to see Toby for a more detailed examination or recommend a change in dosage or medication.
3. Monitor Toby closely: Keep a close eye on Toby's movements and overall condition. Observe if there are any changes or worsening of symptoms. Document any new information or observations regarding his AIMS score.
4. Communicate with the healthcare team: Share the AIMS score and any relevant information with the rest of the healthcare team involved in Toby's care. This ensures that everyone is aware of his current condition and can provide appropriate support.
5. Educate Toby and his family: Take the time to explain to Toby and his family the significance of the AIMS score and the potential implications. Discuss any recommended changes in medication or further assessments that may be needed. Address any concerns or questions they may have to ensure they are well-informed and involved in the decision-making process.
Remember, each patient and situation is unique, so the specific actions taken may vary. It is important to follow the guidelines and instructions provided by the doctor and collaborate closely with the healthcare team to provide the best possible care for Toby.
Learn more about olanzapine at
https://brainly.com/question/30268547
#SPJ11
the bone marrow is hypercellular, with 20 to 90% leukemic blasts at diagnosis or relapse. the blasts grow indiscriminately, but the cells have limited differentiation capability and are frozen in the earliest stage of development
The statement "the bone marrow is hypercellular, with 20 to 90% leukemic blasts at diagnosis or relapse. the blasts grow indiscriminately, but the cells have limited differentiation capability and are frozen in the earliest stage of development" is true.
The bone marrow is hypercellular, meaning there is an excessive amount of cells present. In this case, the bone marrow contains 20 to 90% leukemic blasts at the time of diagnosis or relapse. Leukemic blasts are immature white blood cells that are characteristic of leukemia.
These leukemic blasts grow without regulation or control, leading to an overgrowth in the bone marrow. However, despite their rapid growth, these cells have limited differentiation capability. This means that they are unable to mature and develop into their intended specialized cell types. Instead, the leukemic blasts remain frozen or stuck in the earliest stage of development. This lack of differentiation contributes to the aggressive nature of leukemia, as the immature cells are unable to carry out their normal functions and disrupt the normal functioning of the bone marrow.
To summarize, in leukemia, the bone marrow becomes hypercellular with an abundance of leukemic blasts. These blasts grow uncontrollably and have limited differentiation capability, remaining frozen in their earliest developmental stage.
Learn more about bone marrow: https://brainly.com/question/30754540
#SPJ11